fbpx
  • Home
  • Study Details
By physician referral or invitation only

A nasal swab study to assess the efficacy of vaccination in the prevention of SARS-CoV-2 infection among individuals enrolled in a Phase 3 efficacy trial of a SARS-CoV-2 recombinant spike protein (rS) vaccine with Matrix-M1™ (M1) adjuvant

This study aims to estimate the efficacy of SARS-CoV-2 rS/M1 vaccine against infection

Age & Gender

  • 12 years ~ 17 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

United States (Nationwide)

Additional Study Information

Principal Investigator

Cindy Gay
Medicine-Infectious Diseases

Study Type

Clinical or Medical
Observational

Study Topics

Immune System/Infections
COVID-19

IRB Number

21-1460

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.